Revlimid capsules 5mg, manufactured by Bristol-Myers Squibb, contains Lenalidomide hydrate, which is prescribed for multiple myeloma, myelodysplastic syndromes, follicular lymphoma, and mantle cell lymphoma. This 5mg 1 capsule formulation is identified by YJ code 4291024M1024.
Revlimid capsules 5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
